Present Its News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Present Its. Real-time updates on events, politics, business and more.

Kintara Therapeutics : TuHURA Biosciences to Present Its IFx-2.0 Personalized Cancer Vaccine Clinical Trial Results at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - Form 8-K

April 25, 2024

TuHURA Biosciences to Present Its IFx-2.0 Personalized Cancer Vaccine Clinical Trial Results at the 2024 American Society of Clinical Oncology Annual Meeting TAMPA, FL&SAN...

United States San Diego Jenene Thomas Andrew Brohl Roberte Hoffman Tuhura Biosciences Inc

Source: marketscreener.com

Chemomab Therapeutics to Present Its CM-101 Clinical Program in Primary Sclerosing Cholangitis at 2023 Roth MKM Healthcare Opportunities Conference

September 28, 2023

Chemomab Therapeutics Ltd. , (Chemomab), a clinical stage biotechnology company developing innovative therapeutics to treat rare...

New York United States Barbara Lindheim Wadi Mor Clinical Program In Primary Sclerosing Cholangitis Yale Club

Source: lelezard.com

CEQA Year in Review 2021 | Perkins Coie

January 19, 2022

A Summary of Published Appellate Opinions Under the California Environmental Quality Act - Introduction - The courts issued relatively few published CEQA...

City Of San Jose United States Pioneer Monument Squaw Valley Angeles National Forest Civic Center

Source: jdsupra.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Present Its News Today

Kintara Therapeutics : TuHURA Biosciences to Present Its IFx-2.0 Personalized Cancer Vaccine Clinical Trial Results at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - Form 8-K

Chemomab Therapeutics to Present Its CM-101 Clinical Program in Primary Sclerosing Cholangitis at 2023 Roth MKM Healthcare Opportunities Conference

CEQA Year in Review 2021 | Perkins Coie

Explore More Categories